Acacias in the Arava – past, present and future
The Dead Sea-Arava Science Center, October 23-24th
Central Arava, Yair station, Weiber auditorium
Registration and welcome coffee Welcome notes: Dr. Eyal Bloom, Head of the Central Arava Regional Council
09:30-09:45 Dr. Hanan Ginat, The Dead Sea Arava Science Center
Session 1 – Physiology. Chair: Gidon Winters
Walter’s two-layer hypothesis revisited – back to the roots!
09:50-10:10 D. Ward, K. Wiegand, S. Getzin
A methodological approach to determine age and growth rate of ringless trees
10:10-10:30 Knut Krzywinski, Gidske L. Andersen, Tomasz Goslar, Mary Gagen, Giles Young
Acacia ssp.and Pistacia atlantica in Israel: Carbon isotopes approach to study climate-
50 Valentina Caracuta, Lior Regev, Michael Richards, Itshack Moshe, Gidon Winters, Elisabetta
Indicators of water stress on three acacia species in the Arava valley, Israel
10:50-11:10 Raphael Breit, Ilan Stavi, Elain Soloway, Elli Groner
Coffee break Session 2 – Ecology and genetics. Chair: Elli Groner
Traditional tending and use of Acacia tortilis : long-term effects up on population viability
11:30-11:50 Gidske L. Andersen, Knut Krzywinski, Mohamed Talib,Ahmed Ebaid, Joseph J. Hobbs,
Acacia trees: leave extracts contain anti-cancer (pro-apoptotic) activity
Acacias in the Arava – past, present and future
The Dead Sea-Arava Science Center, October 23-24th
Central Arava, Yair station, Weiber auditorium
Day 1 (October 23) – lectures (continued):
Genetic analysis of selected local acacia planted in suspects hybrids (A. negevensis X A.
12:10-12:30 raddiana) for suitability to different habitats in the South
Symbiosis and multi-trophic networks in the aid of Acacia’s seed dispersal
Acacia trees: Key stone species for insectivorous bats in the Arava desert
12:50-13:10 Carmi Korine, Talya D. Hackett and Marc W. Holderied
Lunch break Tour to the laboratories of the Dead Sea Arava Science Center Session 3 – Monitoring. Chair: Asaf Tsoar
Biomass, Leaf Area index and Productivity assessment in trees and forests: experiences,
Giorgio Matteucci, Ettore D’Andrea, Bruno De Cinti, Marco Bascietto
Acacia trees survey in the Arava valley – results and implications
14:20-14:40 Amir Perelberg, Mimi Ron, Uri Ramon
Designing a long term monitoring protocol for acacia populations in the Arava
Elli Groner , Gidon Winters , Hanan Ginat , Ilan Stavi , Benny Shalmon, Roey Talbi, Asaf
14:40-15:00 Tsoar, Mimi Ron , Uri Ramon , Amir Perlberg , Naama Berg, Zohar Tsafon Sivan Issacson,
Preliminary analysis of long and short term spatial processes of Acacia population using a
15:00-15:20 single near infra-red aerial photograph
Sivan Isaacson, Dan J. Blumberg, Jhonathan E. Ephrath, Shimon Rachmilevitch
Following changes in Acacia physiology - The Gidorn Wadi as a case study
15:25-15:40 Ina Ryvkin, Tali Rodkov, Eitan Barel, Gidon Winters
15:40-16:30 Open discussion on monitoring session
Acacias in the Arava – past, present and future
The Dead Sea-Arava Science Center, October 23-24th
Central Arava, Yair station, Weiber auditorium
On the 24th of October we will demonstrate how to monitor the acacia. Recently a few
bodies have agreed on a joint protocol. These include all part of the LTER, KKL-JNF and the
Israeli National Parks Authority (INPA), and the Dead Sea Arava Science Center (ADSSC).
We will demonstrate the monitoring and discuss pros and cons of the different methods. It is
expected that during November the monitoring will start. Everyone is invited.
Starting time Finishing time Demonstrator
SAFETY DATA SHEET AGRORAT WARFA-20%. (WARFARIN 20 %) Issue date: 27.12.04 1. - Substance and company identification Identification of the substance or of the preparation. Technical active ingredient for rodenticides formulation Identification of the society or company. Emergency telephone : + 34 91 562 04 20 2.- Composition / information on ingredients. Product : Warf
Biological, Pharmacological, and Somatic Treatments for Obsessive-Compulsive Disorder Michele T. Pato, MD Katharine A. Phillips, MD For many patients, obsessive-compulsive disorder is a lifelong illness extending from early childhood into adulthood. However, pharmacological and behavioral treatments at adequate doses and duration offer a majority of patients improvement in symptomsand fun